Featured Series
A video summary of key sessions from the meeting in Vancouver.
Where Neurology and #Culture Intersect
Read More
An investigational BACE inhibitor for the treatment of early Alzheimer’s disease is moving into Phase 3 trials, following confirmation from the FDA. Developed in a partn… read more
The FDA has approved Zinbryta (daclizumab, Biogen/AbbVie), a once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis (RMS). The … read more
NFL player Eugene Monroe has donated $80,000 to researchers at Johns Hopkins University and the University of Pennsylvania to examine the therapeutic potential of cannabinoid … read more
The FDA has approved Nuplazid (pimavanserin) from Acadia Pharmaceuticals for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis, whi… read more
The American Academy of Neurology (AAN) has adopted new guidelines for the use of botulinum toxins for blepharospasm, cervical dystonia (CD), headache, and adult spasticity. T… read more
Vertebral Artery Dissection (VAD) refers to a non-hemorrhagic cerebrovascular event caused by a flap-like tear in t…
Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.
